XNAS · Healthcare · Medical Devices
CeriBell Inc is a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The company has developed the Ceribell System, a novel, point-of-care electroencephalography (EEG) platform designed to address the unmet needs of patients in the acute care setting. By combining proprietary, portable, and rapidly deployable hardware with sophisticated artificial intelligence (AI)-powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions. Its products are Point-of-Care EEG, Clarity, and EEG Portal.
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-10 | Q2 2026 | -0.46 | -0.51 | -10.87% | $28.1M | ❌ Miss | +0.78% | +26.42% | — |
| 2026-05-11 | Q1 2026 | -0.39 | -0.52 | -33.33% | $26.5M | ❌ Miss | +0.00% | -17.35% | -8.37% |
| 2026-02-24 |
| Q4 2025 |
| -0.42 |
| -0.36 |
| +14.29% |
| $24.8M |
| ✅ Beat |
| +1.96% |
| -11.86% |
| -7.54% |
| 2025-11-04 | Q3 2025 | -0.42 | -0.37 | +11.90% | $22.6M | ✅ Beat | — | — | — |
| 2025-08-05 | Q2 2025 | -0.40 | -0.38 | +5.00% | $21.2M | ✅ Beat | +4.77% | -22.41% | -18.24% |
| 2025-02-25 | Q4 2024 | -0.31 | -0.40 | -29.03% | $18.5M | ❌ Miss | -1.33% | -6.97% | -22.36% |
Showing last 6 quarters.